» Articles » PMID: 18950370

Cognitive Functions in Bipolar Affective Disorder and Schizophrenia: Comparison

Overview
Specialties Neurology
Psychiatry
Date 2008 Oct 28
PMID 18950370
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Earlier comparisons of cognitive impairment among patients with bipolar disorder and schizophrenia have found a largely similar profile of deficits, but results have varied between studies. This prompted the current attempt at another such comparison.

Methods: Executive functions, memory, IQ, attention-concentration and perceptuomotor function were assessed in 48 bipolar disorder patients with operationally defined euthymia, and compared with 32 schizophrenia patients in remission, and 23 normal controls. Comparisons were re-attempted after controlling for years of schooling and residual affective symptoms.

Results: Uncontrolled comparisons indicated that, compared to controls, both bipolar disorder and schizophrenia patients were significantly impaired on different tests of executive function, memory, IQ and perceptuomotor functions. Controlling for years of schooling and residual affective symptoms, however, served to remove most of the differences between patients and controls, apart from some aspects of executive function in schizophrenia and memory impairment in both schizophrenia and bipolar disorder. Patients with schizophrenia consistently performed worse than patients with bipolar disorder, but none of the differences between schizophrenia and bipolar disorder were significant.

Conclusions: Patients with bipolar disorder exhibit cognitive difficulties that are very similar to schizophrenia in terms of their profile, although patients with schizophrenia may have more severe and widespread impairments. The resemblance in cognitive profiles has important implications for the etiology and treatment of both disorders.

Citing Articles

Factors associated with suicide attempts in the antecedent illness trajectory of bipolar disorder and schizophrenia.

Miola A, Gardea-Resendez M, Ortiz-Orendain J, Nunez N, Ercis M, Coombes B Int J Bipolar Disord. 2023; 11(1):38.

PMID: 38063942 PMC: 10709261. DOI: 10.1186/s40345-023-00318-3.


Antecedents to first episode psychosis and mania: Comparing the initial prodromes of schizophrenia and bipolar disorder in a retrospective population cohort.

Ortiz-Orendain J, Gardea-Resendez M, Castiello-de Obeso S, Golebiowski R, Coombes B, Gruhlke P J Affect Disord. 2023; 340:25-32.

PMID: 37506772 PMC: 10883376. DOI: 10.1016/j.jad.2023.07.106.


A systematic review of research on neuropsychological measures in psychotic disorders from low and middle-income countries: The question of clinical utility.

Mwesiga E, Akena D, Koen N, Senono R, Obuku E, Gumikiriza J Schizophr Res Cogn. 2020; 22:100187.

PMID: 32874938 PMC: 7451606. DOI: 10.1016/j.scog.2020.100187.


Potential biomarkers for bipolar disorder: Where do we stand?.

Sagar R, Pattanayak R Indian J Med Res. 2017; 145(1):7-16.

PMID: 28574009 PMC: 5460576. DOI: 10.4103/ijmr.IJMR_1386_16.


Neurocognitive Functioning in Schizophrenia, their Unaffected Siblings and Healthy Controls: A Comparison.

Nehra R, Grover S, Sharma S, Sharma A, Kate N Indian J Psychol Med. 2016; 38(1):50-5.

PMID: 27011403 PMC: 4782445. DOI: 10.4103/0253-7176.175114.